Loading…

The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations

Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the s...

Full description

Saved in:
Bibliographic Details
Published in:Human reproduction (Oxford) 2000-05, Vol.15 (5), p.1079-1082
Main Authors: Thomas, K., Coughlin, L., Mannion, P.T., Haddad, N.G.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3
cites
container_end_page 1082
container_issue 5
container_start_page 1079
container_title Human reproduction (Oxford)
container_volume 15
creator Thomas, K.
Coughlin, L.
Mannion, P.T.
Haddad, N.G.
description Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P < 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.
doi_str_mv 10.1093/humrep/15.5.1079
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71075191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/15.5.1079</oup_id><sourcerecordid>71075191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</originalsourceid><addsrcrecordid>eNqNkEFv1DAQhS0EotvCnRPKAXFBae04duwjWgFFKuLQLaq4WBPH7hqSONhO1f33dZQV5chpRqPvzZt5CL0h-JxgSS_28xDMdEHYOcuDRj5DG1JzXFaU4edogysuSkI4OUGnMf7COLeCv0QnmRWUMr5BsNub4h762RTeFtt9D8Ohc1CkAHrvB0guFjAm1_ruUCQTkxvvCojFBCEtiuDnPDKFG60JyfUuHXJ_v4B3WezH-Aq9sNBH8_pYz9DN50-77WV59f3L1-3Hq1LXkqaywrXVUjJtKJYY2gqsaDkztbCVFKQRTSOxqLE1tGsE01zUrCNVJTm2uMWGnqH3694p-D9zPkANLmrT9zAaP0fV5KcZkSSDeAV18DEGY9UU3ADhoAhWS6xqjVURpphaYs2St8fdczuY7h_BmmMG3h0BiBp6G2DULj5xVEpSLdYfVszP0_-4livtYjIPf3kIvxVvaMPU5e1Pxdhu--369kf2eATzX5_S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71075191</pqid></control><display><type>article</type><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</creator><creatorcontrib>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</creatorcontrib><description>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P &lt; 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/15.5.1079</identifier><identifier>PMID: 10783356</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Anti-Bacterial Agents - therapeutic use ; antibody ; Biological and medical sciences ; Chlamydia Infections - diagnosis ; Chlamydia Infections - drug therapy ; Chlamydia trachomatis ; Chlamydia trachomatis - immunology ; Endoscopy ; Enzyme-Linked Immunosorbent Assay - methods ; Fallopian Tube Diseases - epidemiology ; Fallopian Tube Diseases - microbiology ; Fallopian Tube Diseases - pathology ; Fallopian Tube Patency Tests ; Fallopian Tubes - pathology ; Female ; Fluorescent Antibody Technique, Indirect ; Genital system ; Humans ; hysterosalpingography ; Hysterosalpingography - methods ; Immunoglobulin G - blood ; Incidence ; Infertility, Female - epidemiology ; Infertility, Female - microbiology ; Infertility, Female - pathology ; Investigative techniques, diagnostic techniques (general aspects) ; Laparoscopy ; Medical sciences ; tubal damage</subject><ispartof>Human reproduction (Oxford), 2000-05, Vol.15 (5), p.1079-1082</ispartof><rights>European Society of Human Reproduction and Embryology 2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1399121$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10783356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomas, K.</creatorcontrib><creatorcontrib>Coughlin, L.</creatorcontrib><creatorcontrib>Mannion, P.T.</creatorcontrib><creatorcontrib>Haddad, N.G.</creatorcontrib><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P &lt; 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibody</subject><subject>Biological and medical sciences</subject><subject>Chlamydia Infections - diagnosis</subject><subject>Chlamydia Infections - drug therapy</subject><subject>Chlamydia trachomatis</subject><subject>Chlamydia trachomatis - immunology</subject><subject>Endoscopy</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Fallopian Tube Diseases - epidemiology</subject><subject>Fallopian Tube Diseases - microbiology</subject><subject>Fallopian Tube Diseases - pathology</subject><subject>Fallopian Tube Patency Tests</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Genital system</subject><subject>Humans</subject><subject>hysterosalpingography</subject><subject>Hysterosalpingography - methods</subject><subject>Immunoglobulin G - blood</subject><subject>Incidence</subject><subject>Infertility, Female - epidemiology</subject><subject>Infertility, Female - microbiology</subject><subject>Infertility, Female - pathology</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Laparoscopy</subject><subject>Medical sciences</subject><subject>tubal damage</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqNkEFv1DAQhS0EotvCnRPKAXFBae04duwjWgFFKuLQLaq4WBPH7hqSONhO1f33dZQV5chpRqPvzZt5CL0h-JxgSS_28xDMdEHYOcuDRj5DG1JzXFaU4edogysuSkI4OUGnMf7COLeCv0QnmRWUMr5BsNub4h762RTeFtt9D8Ohc1CkAHrvB0guFjAm1_ruUCQTkxvvCojFBCEtiuDnPDKFG60JyfUuHXJ_v4B3WezH-Aq9sNBH8_pYz9DN50-77WV59f3L1-3Hq1LXkqaywrXVUjJtKJYY2gqsaDkztbCVFKQRTSOxqLE1tGsE01zUrCNVJTm2uMWGnqH3694p-D9zPkANLmrT9zAaP0fV5KcZkSSDeAV18DEGY9UU3ADhoAhWS6xqjVURpphaYs2St8fdczuY7h_BmmMG3h0BiBp6G2DULj5xVEpSLdYfVszP0_-4livtYjIPf3kIvxVvaMPU5e1Pxdhu--369kf2eATzX5_S</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Thomas, K.</creator><creator>Coughlin, L.</creator><creator>Mannion, P.T.</creator><creator>Haddad, N.G.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000501</creationdate><title>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</title><author>Thomas, K. ; Coughlin, L. ; Mannion, P.T. ; Haddad, N.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibody</topic><topic>Biological and medical sciences</topic><topic>Chlamydia Infections - diagnosis</topic><topic>Chlamydia Infections - drug therapy</topic><topic>Chlamydia trachomatis</topic><topic>Chlamydia trachomatis - immunology</topic><topic>Endoscopy</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Fallopian Tube Diseases - epidemiology</topic><topic>Fallopian Tube Diseases - microbiology</topic><topic>Fallopian Tube Diseases - pathology</topic><topic>Fallopian Tube Patency Tests</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Genital system</topic><topic>Humans</topic><topic>hysterosalpingography</topic><topic>Hysterosalpingography - methods</topic><topic>Immunoglobulin G - blood</topic><topic>Incidence</topic><topic>Infertility, Female - epidemiology</topic><topic>Infertility, Female - microbiology</topic><topic>Infertility, Female - pathology</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Laparoscopy</topic><topic>Medical sciences</topic><topic>tubal damage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomas, K.</creatorcontrib><creatorcontrib>Coughlin, L.</creatorcontrib><creatorcontrib>Mannion, P.T.</creatorcontrib><creatorcontrib>Haddad, N.G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, K.</au><au>Coughlin, L.</au><au>Mannion, P.T.</au><au>Haddad, N.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>15</volume><issue>5</issue><spage>1079</spage><epage>1082</epage><pages>1079-1082</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>Laparoscopy is considered the gold standard for the evaluation of tubal disease but it is an invasive and costly procedure. Chlamydia trachomatis antibody testing is simple and inexpensive and causes minimal inconvenience to the patient. Using the micro-immunofluorescence technique we assessed the significance of positive serology. There was a marked association between the titre and the likelihood of tubal damage. In the group with low titres (1 in 32) there was only a 5% incidence of tubal damage; however, there was a progressive increase in the incidence of tubal damage in those with higher titres. Twenty out of 57 patients with titres higher than 1 in 32 had tubal damage (35%). The difference between the two groups was statistically significant (P &lt; 0.0001, χ2 test). By using C. trachomatis antibody testing more widely it may be possible to reduce the number of laparoscopies performed. It should therefore become an integral part of the fertility work-up.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>10783356</pmid><doi>10.1093/humrep/15.5.1079</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2000-05, Vol.15 (5), p.1079-1082
issn 0268-1161
1460-2350
1460-2350
language eng
recordid cdi_proquest_miscellaneous_71075191
source Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)
subjects Anti-Bacterial Agents - therapeutic use
antibody
Biological and medical sciences
Chlamydia Infections - diagnosis
Chlamydia Infections - drug therapy
Chlamydia trachomatis
Chlamydia trachomatis - immunology
Endoscopy
Enzyme-Linked Immunosorbent Assay - methods
Fallopian Tube Diseases - epidemiology
Fallopian Tube Diseases - microbiology
Fallopian Tube Diseases - pathology
Fallopian Tube Patency Tests
Fallopian Tubes - pathology
Female
Fluorescent Antibody Technique, Indirect
Genital system
Humans
hysterosalpingography
Hysterosalpingography - methods
Immunoglobulin G - blood
Incidence
Infertility, Female - epidemiology
Infertility, Female - microbiology
Infertility, Female - pathology
Investigative techniques, diagnostic techniques (general aspects)
Laparoscopy
Medical sciences
tubal damage
title The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20value%20of%20Chlamydia%20trachomatis%20antibody%20testing%20as%20part%20of%20routine%20infertility%20investigations&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Thomas,%20K.&rft.date=2000-05-01&rft.volume=15&rft.issue=5&rft.spage=1079&rft.epage=1082&rft.pages=1079-1082&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/15.5.1079&rft_dat=%3Cproquest_cross%3E71075191%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-204fc995ce3090ab2af8b65e48f2981787790840fe3d785c6845d122960f0b0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71075191&rft_id=info:pmid/10783356&rft_oup_id=10.1093/humrep/15.5.1079&rfr_iscdi=true